Dengue pathogenesis: A disease driven by the host response

Science Progress

Volumn 97, Issue 3, 2014, Pages 197-214

  Martina, Byron E E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cytokine storm; Dengue pathogenesis; Genotype; Host response; Severe disease

Indexed keywords

CYTOKINE; VIRUS ANTIBODY;

AEDES; ANIMAL; BLOOD; DENGUE; DENGUE VIRUS; DISEASE CARRIER; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOGENICITY; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY; VIRULENCE;

AEDES; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; DENGUE; DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INSECT VECTORS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; VIRULENCE;

EID: 84907084106     PISSN: 00368504     EISSN: 20477163     Source Type: Journal    
DOI: 10.3184/003685014X14049173153889     Document Type: Article

References (74)

1. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L. et al., (2013) The global distribution and burden of dengue. Nature, 496, 504-507.
2. Gibbons, R.V. and Vaughn, D.W. (2002) Dengue: an escalating problem. BMJ, 324, 1563-1566.
3. Murray, N.E., Quam, M.B. and Wilder-Smith, A. (2013) Epidemiology of dengue: past, present and future prospects. Clin. Epidemiol., 5, 299-309.
4. Richards, S.L., Anderson, S.L. and Alto, B.W. (2012) Vector competence of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) for dengue virus in the Florida Keys. J. Med. Entomol., 49, 942-946.
5. Vega-Rua, A., Zouache, K., Caro, V., Diancourt, L., Delaunay, P., Grandadam, M. and Failloux, A.B. (2013) High efficiency of temperate Aedes albopictus to transmit chikungunya and dengue viruses in the Southeast of France. PLoS One, 8, e59716.
6. Junjhon, J., Edwards, T.J., Utaipat, U., Bowman, V.D., Holdaway, H.A., Zhang, W. et al. (2010) Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J. Virol., 84, 8353-8358.
7. Smit, J.M., Moesker, B., Rodenhuis-Zybert, I. and Wilschut, J. (2011) Flavivirus cell entry and membrane fusion. Viruses, 3, 160-171.
8. Kwan, W.H., Helt, A.M., Maranon, C., Barbaroux, J.B., Hosmalin, A., Harris, E. et al. (2005) Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J. Virol., 79, 7291-7299.
9. Kwan, W.H., Navarro-Sanchez, E., Dumortier, H., Decossas, M., Vachon, H., dos Santos, F.B. et al. (2008) Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl. Trop. Dis., 2, e311.
10. Lin, Y.W., Wang, K.J., Lei, H.Y., Lin, Y.S., Yeh, T.M., Liu, H.S. et al. (2002) Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J. Virol., 76, 12242-12249.
11. Sun, J., Luo, S., Lin, J., Chen, J., Hou, J., Fu, T. et al. (2012) Inapparent infection during an outbreak of dengue fever in Southeastern China. Viral Immunol., 25, 456-460.
12. Huy, N.T., Van Giang, T., Thuy, D.H., Kikuchi, M., Hien, T.T., Zamora, J. and Hirayama, K. (2013) Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop. Dis., 7, e2412.
13. Ho, T.S., Wang, S.M., Lin, Y.S. and Liu, C.C. (2013) Clinical and laboratory predictive markers for acute dengue infection. J. Biomed. Sci., 20, 75.
14. Kalayanarooj, S., Vaughn, D.W., Nimmannitya, S., Green, S., Suntayakorn, S., Kunentrasai, N. et al. (1997) Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis., 176, 313-321.
15. Odreman-Macchioli, M., Vielma, S., Atchley, D., Comach, G., Ramirez, A., Perez, S. et al. (2013) Analysis of real time PCR amplification efficiencies from three genomic region of dengue virus. Invest. Clin., 54, 5-19.
16. Teoh, B.T., Sam, S.S., Tan, K.K., Johari, J., Danlami, M.B., Hooi, P.S. et al. (2013) Detection of dengue viruses using reverse transcription-loop-mediated isothermal amplification. BMC Infect. Dis., 13, 387.
17. Waggoner, J.J., Abeynayake, J., Sahoo, M.K., Gresh, L., Tellez, Y., Gonzalez, K. et al. (2013) Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J. Clin. Microbiol., 51, 2172-2181.
18. Waggoner, J.J., Abeynayake, J., Sahoo, M.K., Gresh, L., Tellez, Y., Gonzalez, K. et al. (2013) Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl. Trop. Dis., 7, e2116.
19. Santiago, G.A., Vergne, E., Quiles, Y., Cosme, J., Vazquez, J., Medina, J.F. et al. (2013) Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop. Dis., 7, e2311.
20. De La Cruz Hernandez, S.I., Flores-Aguilar, H., Gonzalez-Mateos, S., Lopez-Martinez, I., Ortiz-Navarrete, V., Ludert, J.E. and Del Angel, R.M. (2013) Viral load in patients infected with dengue is modulated by the presence of anti-dengue IgM antibodies. J. Clin. Virol., 58, 258-261.
21. Moi, M.L., Omatsu, T., Tajima, S., Lim, C.K., Kotaki, A., Ikeda, M. et al. (2013) Detection of dengue virus nonstructural protein 1 (NS1) by using ELISA as a useful laboratory diagnostic method for dengue virus infection of international travelers. J. Travel Med., 20, 185-193.
22. da Lima M.R., Nogueira, R.M., Schatzmayr, H.G. and dos Santos, F.B. (2010) Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl. Trop. Dis., 4, e738.
23. Duong, V., Ly, S., Lorn Try, P., Tuiskunen, A., Ong, S., Chroeung, N. et al. (2011) Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl. Trop. Dis., 5, e1244.
24. Vazquez, S., Ruiz, D., Barrero, R., Ramirez, R., Calzada, N., del Rosario Pena, B. et al. (2010) Kinetics of dengue virus NS1 protein in dengue 4-confirmed adult patients. Diagn. Microbiol. Infect. Dis., 68, 46-49.
25. Prince, H.E. and Matud, J.L. (2011) Estimation of dengue virus IgM persistence using regression analysis. Clin. Vaccine Immunol., 18, 2183-2185.
26. Puschnik, A., Lau, L., Cromwell, E.A., Balmaseda, A., Zompi, S. and Harris, E. (2013) Correlation between dengue-specific neutralising antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl. Trop. Dis., 7, e2274.
27. Namekar, M., Ellis, E.M., O'Connell, M., Elm, J., Gurary, A., Park, S.Y. et al. (2013) Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection. J. Clin. Microbiol., 51, 3102-3106.
28. Pan-ngum, W., Blacksell, S.D., Lubell, Y., Pukrittayakamee, S., Bailey, M.S., de Silva, H.J. et al. (2013) Estimating the true accuracy of diagnostic tests for dengue infection using Bayesian latent class models. PLoS One, 8, e50765.
29. Blacksell, S.D., Jarman, R.G., Gibbons, R.V., Tanganuchitcharnchai, A., Mammen, M.P., Jr., Nisalak, A. et al. (2012) Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin. Vaccine Immunol., 19, 804-810.
30. Rico-Hesse, R. (2003) Microevolution and virulence of dengue viruses. Adv. Virus Res., 59, 315-341.
31. Rico-Hesse, R. (1990) Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology, 174, 479-493.
32. Alfonso, H.L., Amarilla, A.A., Goncalves, P.F., Barros, M.T., de Almeida, F.T., Silva, T.R. et al. (2012) Phylogenetic relationship of dengue virus type 3 isolated in Brazil and Paraguay and global evolutionary divergence dynamics. Virol. J., 9, 124.
33. Cologna, R., Armstrong, P.M. and Rico-Hesse, R. (2005) Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol., 79, 853-859.
34. Sharp, T.M., Hunsperger, E., Santiago, G.A., Munoz-Jordan, J.L., Santiago, L.M., Rivera, A. et al. (2013) Virusspecific differences in rates of disease during the 2010 Dengue epidemic in Puerto Rico. PLoS Negl. Trop. Dis., 7, e2159.
35. Cruz, C.D., Forshey, B.M., Juarez, D.S., Guevara, C., Leguia, M., Kochel, T.J. and Halsey, E.S. (2013) Molecular epidemiology of American/Asian genotype DENV-2 in Peru. Infect. Genet. Evol., 18, 220-228.
36. Halsey, E.S., Marks, M.A., Gotuzzo, E., Fiestas, V., Suarez, L., Vargas, J. et al. (2012) Correlation of serotypespecific dengue virus infection with clinical manifestations. PLoS Negl. Trop. Dis., 6, e1638.
37. Barcelos Figueiredo, L., Batista Cecilio, A., Portela Ferreira, G., Paiva Drumond, B., Germano de Oliveira, J., Bonjardim, C.A. et al. (2008) Dengue virus 3 genotype 1 associated with dengue fever and dengue haemorrhagic fever, Brazil. Emerg. Infect. Dis., 14, 314-316.
38. Rico-Hesse, R., Harrison, L.M., Salas, R.A., Tovar, D., Nisalak, A., Ramos, C. et al. (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology, 230, 244-251.
39. Teoh, B.T., Sam, S.S., Tan, K.K., Johari, J., Shu, M.H., Danlami, M.B. et al. (2013) Dengue virus type 1 clade replacement in recurring homotypic outbreaks. BMC Evol Biol., 13, 213.
40. OhAinle, M., Balmaseda, A., Macalalad, A.R., Tellez, Y., Zody, M.C., Saborio, S. et al. (2011) Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci. Transl. Med., 3, 114ra128.
41. Rico-Hesse, R. (2010) Dengue virus virulence and transmission determinants. Curr. Top. Microbiol. Immunol., 338, 45-55.
42. Tuiskunen, A., Monteil, V., Plumet, S., Boubis, L., Wahlstrom, M., Duong, V. et al. (2011) Phenotypic and genotypic characterisation of dengue virus isolates differentiates dengue fever and dengue haemorrhagic fever from dengue shock syndrome. Arch. Virol., 156, 2023-2032.
43. Tuiskunen, A., Wahlstrom, M., Bergstrom, J., Buchy, P., Leparc-Goffart, I. and Lundkvist, A. (2011) Phenotypic characterisation of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue haemorrhagic fever from dengue shock syndrome. Virol. J., 8, 398.
44. Edgil, D., Diamond, M.S., Holden, K.L., Paranjape, S.M. and Harris, E. (2003) Translation efficiency determines differences in cellular infection among dengue virus type 2 strains. Virology, 317, 275-290.
45. Ubol, S., Chareonsirisuthigul, T., Kasisith, J. and Klungthong, C. (2008) Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology, 376, 290-296.
46. Umareddy, I., Tang, K.F., Vasudevan, S.G., Devi, S., Hibberd, M.L. and Gu, F. (2008) Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J. Gen. Virol., 89, 3052-3062.
47. Duarte dos Santos, C.N., Frenkiel, M.P., Courageot, M.P., Rocha, C.F., Vazeille-Falcoz, M.C., Wien, M.W. et al. (2000) Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Virology, 274, 292-308.
48. Silveira, G.F., Meyer, F., Delfraro, A., Mosimann, A.L., Coluchi, N., Vasquez, C. et al. (2011) Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J. Virol., 85, 5374-5383.
49. Martina, B.E., Koraka, P. and Osterhaus, A.D. (2009) Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev., 22, 564-581.
50. Silva, L.K., Blanton, R.E., Parrado, A.R., Melo, P.S., Morato, V.G., Reis, E.A. et al. (2010) Dengue haemorrhagic fever is associated with polymorphisms in JAK1. Eur. J. Hum. Genet., 18, 1221-1227.
51. Whitehorn, J., Chau, T.N., Nguyet, N.M., Kien, D.T., Quyen, N.T., Trung, D.T. et al. (2013) Genetic variants of MICB and PLCE1 and associations with non-severe dengue. PLoS One, 8, e59067.
52. Terajima, M., Hendershot, J.D., 3rd, Kariwa, H., Koster, F.T., Hjelle, B., Goade, D. et al. (1999) High levels of viraemia in patients with the Hantavirus pulmonary syndrome. J. Infect. Dis., 180, 2030-2034.
53. Sanchez, A., Lukwiya, M., Bausch, D., Mahanty, S., Sanchez, A.J., Wagoner, K.D. and Rollin, P.E. (2004) Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) haemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol., 78, 10370-10377.
54. Duh, D., Saksida, A., Petrovec, M., Ahmeti, S., Dedushaj, I., Panning, M. et al. (2007) Viral load as predictor of Crimean-Congo haemorrhagic fever outcome. Emerg. Infect. Dis., 13, 1769-1772.
55. Libraty, D.H., Young, P.R., Pickering, D., Endy, T.P., Kalayanarooj, S., Green, S. et al. (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue haemorrhagic fever. J. Infect. Dis., 186, 1165-1168.
56. Libraty, D.H., Endy, T.P., Houng, H.S., Green, S., Kalayanarooj, S., Suntayakorn, S. et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis., 185, 1213-1221.
57. Stramer, S.L., Linnen, J.M., Carrick, J.M., Foster, G.A., Krysztof, D.E., Zou, S. et al. (2012) Dengue viraemia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion, 52, 1657-1666.
58. Wahala, W.M. and Silva, A.M. (2011) The human antibody response to dengue virus infection. Viruses, 3, 2374-2395.
59. van der Schaar, H.M., Wilschut, J.C. and Smit, J.M. (2009) Role of antibodies in controlling dengue virus infection. Immunobiology, 214, 613-629.
60. Guzman, M.G., Alvarez, M. and Halstead, S.B. (2013) Secondary infection as a risk factor for dengue haemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol., 158, 1445-1459.
61. Halstead, S.B., Mahalingam, S., Marovich, M.A., Ubol, S. and Mosser, D.M. (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis., 10, 712-722.
62. Ubol, S. and Halstead, S.B. (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin. Vaccine Immunol., 17, 1829-1835.
63. van de Weg, C.A., Pannuti, C.S., de Araujo, E.S., van den Ham, H.J., Andeweg, A.C., Boas, L.S. et al. (2013) Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl. Trop. Dis., 7, e2236.
64. Weiskopf, D., Angelo, M.A., de Azeredo, E.L., Sidney, J., Greenbaum, J.A., Fernando, A.N. et al. (2013) Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. USA, 110, E2046-2053.
65. Malavige, G.N. and Ogg, G.S. (2013) T cell responses in dengue viral infections. J Clin. Virol., 58, 605-611.
66. Wu, M.F., Chen, S.T., Yang, A.H., Lin, W.W., Lin, Y.L., Chen, N.J. et al. (2013) CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood, 121, 95-106.
67. de Martins S.T., Silveira, G.F., Alves, L.R., Duarte dos Santos, C.N. and Bordignon, J. (2012) Dendritic cell apoptosis and the pathogenesis of dengue. Viruses, 4, 2736-2753.
68. Long, X., Li, Y., Qi, Y., Xu, J., Wang, Z., Zhang, X. et al. (2013) XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells. Faseb J., 27, 1062-1073.
69. Rothman, A.L. (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol., 11, 532-543.
70. Mongkolsapaya, J., Dejnirattisai, W., Xu, X.N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A. et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue haemorrhagic fever. Nat. Med., 9, 921-927.
71. Matsuda, T., Almasan, A., Tomita, M., Tamaki, K., Saito, M., Tadano, M. et al. (2005) Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J. Gen. Virol., 86, 1055-1065.
72. Liu, Y., Liu, H., Zou, J., Zhang, B. and Yuan, Z. (2014) Dengue virus subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway. Virology, 448, 15-25.
73. El-Bacha, T., Midlej, V., Pereira da Silva, A.P., Silva da Costa, L., Benchimol, M., Galina, A. and Da Poian, A.T. (2007) Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim. Biophys. Acta, 1772, 1158-1166.
74. van de Weg, C.A., Koraka, P., van Gorp, E.C., Mairuhu, A.T., Supriatna, M., Soemantri, A. et al. (2012) Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J. Clin. Virol., 53, 38-42.